Lincoln Alternative Strategies LLC - Significant Ownership

Signature - Title
/s/ Stephen Temes - Stephen Temes/Managing Member
Location
Miami Beach, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lincoln Alternative Strategies LLC.

Significant Ownership of Lincoln Alternative Strategies LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JAGX Jaguar Health, Inc. Common Stock, par value $0.0001 per share 18.92% $150K 600K Lincoln Alternative Strategies LLC Aug 28, 2025
VMAR Vision Marine Technologies Inc. Common Stock, no par value per share 16.1% $1.04M 750K Lincoln Alternative Strategies LLC Aug 15, 2025
CLDI Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value 14.46% $1.25M 730K Lincoln Alternative Strategies LLC Aug 20, 2025
PPBT PURPLE BIOTECH LTD. American Depositary Shares, each representing 200 Ordinary Shares 9.9% $1.29M 605K Lincoln Alternative Strategies LLC Sep 4, 2025
XRTX XORTX Therapeutics Inc. Common Shares, no par value per share 9.9% $498K 572K Lincoln Alternative Strategies LLC Oct 23, 2025
BCDA BioCardia, Inc. Common Stock, par value $0.001 per share 7.54% $1.56M 800K Lincoln Alternative Strategies LLC Sep 19, 2025
CVM CEL-SCI Corporation Common Stock, par value $0.01 per share 6.94% $6.27M 555K Lincoln Alternative Strategies LLC Aug 27, 2025
SSKN STRATA Skin Sciences, Inc. Common Stock, $0.001 par value 6.9% $743K 366K Lincoln Alternative Strategies LLC Sep 3, 2025
SLXN Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share 6.18% $127K 131K Lincoln Alternative Strategies LLC Sep 12, 2025
LGVN Longeveron Inc. Class A Common Stock, par value $0.001 per share 6.09% $976K 1.18M Lincoln Alternative Strategies LLC Aug 8, 2025
BNGO Bionano Genomics, Inc. Common Stock, par value $0.0001 per share 5.42% $2.07M 525K Lincoln Alternative Strategies LLC Sep 17, 2025
CELU Celularity Inc Class A Common Stock, $0.0001 par value per share 5.14% $4.74M 1.23M Lincoln Alternative Strategies LLC Jul 14, 2025

Schedules 13D/G Reported by Lincoln Alternative Strategies LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.